Développement et validation de méthodes de dosage du midazolam, un marqueur de l'activité des CYP3A, et de la fexofénadine, un substrat de la glycoprotéine P, dans les milieux biologiques
dc.contributor.advisor | Turgeon, Jacques | fr |
dc.contributor.author | Stepanova, Tatiana | fr |
dc.date.accessioned | 2012-05-28T13:56:11Z | |
dc.date.available | 2012-05-28T13:56:11Z | |
dc.date.issued | 2009-10-08 | fr |
dc.date.submitted | 2009 | fr |
dc.identifier.uri | http://hdl.handle.net/1866/8082 | |
dc.subject | Interaction médicamenteuse | fr |
dc.subject | Cytochromes P450 | fr |
dc.subject | Transporteurs membranaires | fr |
dc.subject | Midazolam | fr |
dc.subject | Fexofénadine | fr |
dc.subject | Clarythromycine | fr |
dc.subject | Méthode de quantification | fr |
dc.subject | Drug interaction | fr |
dc.subject | Cytochromes P450 | fr |
dc.subject | Membrane transporters | fr |
dc.subject | Midazolam | fr |
dc.subject | Fexofenadine | fr |
dc.subject | Clarythromycine | fr |
dc.subject | Method of quantification | fr |
dc.title | Développement et validation de méthodes de dosage du midazolam, un marqueur de l'activité des CYP3A, et de la fexofénadine, un substrat de la glycoprotéine P, dans les milieux biologiques | fr |
dc.type | Thèse ou mémoire / Thesis or Dissertation | fr |
etd.degree.discipline | Sciences pharmaceutiques | fr |
etd.degree.grantor | Université de Montréal | fr |
etd.degree.level | Maîtrise / Master's | fr |
etd.degree.name | M. Sc. | fr |
dcterms.description | Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal. | fr |
dcterms.language | fra | fr |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.